[{"edinetCode":"E33416","endDate":"2018\/6\/20","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":810.0,"averageTemporaryStaff":1526.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9362412.0,"sharesOwendPercent":0.6049,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1538.05,"equityRatio":0.397,"cashAndCashEquivalents":2227552000.0,"assets":60043287000.0,"currentAssets":21357880000.0,"fixedAsset":38685407000.0,"tangibleFixedAssets":33474981000.0,"intangibleFixedAssets":264768000.0,"investmentAndOtherAssets":4945657000.0,"liabilities":36238238000.0,"currentLiabilities":25847889000.0,"shorTermDept":100000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":5038486000.0,"fixedLiabilities":10390348000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":8345547000.0,"netAsset":23805049000.0,"capitalStock":23756282000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":15961468000.0,"treasuryStock":-437000.0,"valuationAndConversionAdjustments":48767000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":94869235000.0,"costOfSales":72972036000.0,"grossProfit":21897198000.0,"sgaExpenses":17768376000.0,"salaryAndBenefit":null,"depreciationAndSGA":2830664000.0,"RDExpenses":null,"operatingIncome":4128821000.0,"nonOperatingIncome":559346000.0,"nonOperatingExpenses":310567000.0,"interestExpense":40500000.0,"ordinaryProfit":4377601000.0,"extraordinaryGain":null,"extraordinaryLoss":38228000.0,"incomeBeforeTax":4339372000.0,"incomeTaxes":1221075000.0,"netIncome":3118297000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3118297000.0,"comprehensiveIncome":3157907000.0,"eps":206.55,"dilutedEps":null,"dividendPerShare":null,"per":21.0,"roe":0.16,"cashFlowFromOperatingActivities":5365353000.0,"depreciationAndCashflowFromOperatingActivities":2910030000.0,"cashFlowFromInvestingActivities":-5443048000.0,"cashFlowFromFinancialActivities":190943000.0,"changesInCashAndCashEquivalents":115828000.0,"列1":"asr","submitDate":"2018\/9\/10","stockCode":9267,"accountingYear":"第１期(自　平成29年12月21日　至　平成30年６月20日)","accountingYearStart":"2017\/12\/21","accountingYearEnd":"2018\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2019\/3\/20","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.392,"cashAndCashEquivalents":null,"assets":65100752000.0,"currentAssets":19851503000.0,"fixedAsset":45249248000.0,"tangibleFixedAssets":39500163000.0,"intangibleFixedAssets":288964000.0,"investmentAndOtherAssets":5460120000.0,"liabilities":39554310000.0,"currentLiabilities":21842980000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":5164855000.0,"fixedLiabilities":17711329000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15582262000.0,"netAsset":25546442000.0,"capitalStock":25517321000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":17722513000.0,"treasuryStock":-443000.0,"valuationAndConversionAdjustments":29120000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":76392792000.0,"costOfSales":58584850000.0,"grossProfit":17807941000.0,"sgaExpenses":14919931000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2888010000.0,"nonOperatingIncome":461705000.0,"nonOperatingExpenses":224617000.0,"interestExpense":25758000.0,"ordinaryProfit":3125098000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":3125098000.0,"incomeTaxes":977118000.0,"netIncome":2147979000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2147979000.0,"comprehensiveIncome":2128332000.0,"eps":138.78,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/5\/7","stockCode":9267,"accountingYear":null,"accountingYearStart":"2018\/6\/21","accountingYearEnd":"2019\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2019\/6\/20","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1016.0,"averageTemporaryStaff":1774.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9266412.0,"sharesOwendPercent":0.6104,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1667.6,"equityRatio":0.373,"cashAndCashEquivalents":2443674000.0,"assets":67855228000.0,"currentAssets":21746414000.0,"fixedAsset":46108814000.0,"tangibleFixedAssets":40144302000.0,"intangibleFixedAssets":291174000.0,"investmentAndOtherAssets":5673337000.0,"liabilities":42545410000.0,"currentLiabilities":24692232000.0,"shorTermDept":780000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":5128025000.0,"fixedLiabilities":17853178000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":15697364000.0,"netAsset":25309818000.0,"capitalStock":25278668000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":18272099000.0,"treasuryStock":-788681000.0,"valuationAndConversionAdjustments":31149000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":103897000000.0,"costOfSales":79478201000.0,"grossProfit":24419109000.0,"sgaExpenses":20372285000.0,"salaryAndBenefit":null,"depreciationAndSGA":3222825000.0,"RDExpenses":null,"operatingIncome":4046823000.0,"nonOperatingIncome":641165000.0,"nonOperatingExpenses":382823000.0,"interestExpense":49399000.0,"ordinaryProfit":4305165000.0,"extraordinaryGain":null,"extraordinaryLoss":418931000.0,"incomeBeforeTax":3886234000.0,"incomeTaxes":1188669000.0,"netIncome":2697564000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2697564000.0,"comprehensiveIncome":2679947000.0,"eps":174.7,"dilutedEps":null,"dividendPerShare":null,"per":14.6,"roe":0.11,"cashFlowFromOperatingActivities":4300287000.0,"depreciationAndCashflowFromOperatingActivities":3320085000.0,"cashFlowFromInvestingActivities":-10946621000.0,"cashFlowFromFinancialActivities":6866067000.0,"changesInCashAndCashEquivalents":216121000.0,"列1":"asr","submitDate":"2019\/9\/9","stockCode":9267,"accountingYear":"第２期(自　2018年６月21日　至　2019年６月20日)","accountingYearStart":"2018\/6\/21","accountingYearEnd":"2019\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2019\/9\/20","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.36,"cashAndCashEquivalents":null,"assets":71192587000.0,"currentAssets":22191958000.0,"fixedAsset":49000628000.0,"tangibleFixedAssets":42989395000.0,"intangibleFixedAssets":285824000.0,"investmentAndOtherAssets":5725408000.0,"liabilities":45588312000.0,"currentLiabilities":25148717000.0,"shorTermDept":1154000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":5024445000.0,"fixedLiabilities":20439594000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":18225361000.0,"netAsset":25604275000.0,"capitalStock":25567691000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":18561197000.0,"treasuryStock":-788757000.0,"valuationAndConversionAdjustments":36583000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":28505005000.0,"costOfSales":22423760000.0,"grossProfit":6081244000.0,"sgaExpenses":5467918000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":613326000.0,"nonOperatingIncome":156376000.0,"nonOperatingExpenses":75834000.0,"interestExpense":11721000.0,"ordinaryProfit":693869000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":693869000.0,"incomeTaxes":215053000.0,"netIncome":478815000.0,"netIncomeAttributableToOwnersOfTheParentCompany":478815000.0,"comprehensiveIncome":484249000.0,"eps":31.55,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/11\/1","stockCode":9267,"accountingYear":null,"accountingYearStart":"2019\/6\/21","accountingYearEnd":"2020\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2019\/12\/20","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9167552.0,"sharesOwendPercent":0.604,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.343,"cashAndCashEquivalents":2116161000.0,"assets":75301896000.0,"currentAssets":24049631000.0,"fixedAsset":51252265000.0,"tangibleFixedAssets":45151617000.0,"intangibleFixedAssets":304389000.0,"investmentAndOtherAssets":5796258000.0,"liabilities":49443105000.0,"currentLiabilities":25274471000.0,"shorTermDept":500000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":4839695000.0,"fixedLiabilities":24168633000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":21906162000.0,"netAsset":25858791000.0,"capitalStock":25825209000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":18818772000.0,"treasuryStock":-788813000.0,"valuationAndConversionAdjustments":31118000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":56330088000.0,"costOfSales":44265666000.0,"grossProfit":12064421000.0,"sgaExpenses":10944356000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1120065000.0,"nonOperatingIncome":310116000.0,"nonOperatingExpenses":183446000.0,"interestExpense":27626000.0,"ordinaryProfit":1246734000.0,"extraordinaryGain":null,"extraordinaryLoss":162182000.0,"incomeBeforeTax":1084551000.0,"incomeTaxes":348162000.0,"netIncome":736389000.0,"netIncomeAttributableToOwnersOfTheParentCompany":736389000.0,"comprehensiveIncome":736358000.0,"eps":48.52,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-85686000.0,"depreciationAndCashflowFromOperatingActivities":1789885000.0,"cashFlowFromInvestingActivities":-5660288000.0,"cashFlowFromFinancialActivities":5418462000.0,"changesInCashAndCashEquivalents":-327512000.0,"列1":"q2r","submitDate":"2020\/1\/31","stockCode":9267,"accountingYear":null,"accountingYearStart":"2019\/6\/21","accountingYearEnd":"2020\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2020\/3\/20","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.327,"cashAndCashEquivalents":null,"assets":81514543000.0,"currentAssets":28342295000.0,"fixedAsset":53172247000.0,"tangibleFixedAssets":46965445000.0,"intangibleFixedAssets":306204000.0,"investmentAndOtherAssets":5900597000.0,"liabilities":54877266000.0,"currentLiabilities":28623226000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":5613083000.0,"fixedLiabilities":26254039000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":23950366000.0,"netAsset":26637276000.0,"capitalStock":26617839000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":19611401000.0,"treasuryStock":-788813000.0,"valuationAndConversionAdjustments":13430000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":86202557000.0,"costOfSales":67434932000.0,"grossProfit":18767624000.0,"sgaExpenses":16324802000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2442822000.0,"nonOperatingIncome":459156000.0,"nonOperatingExpenses":235941000.0,"interestExpense":42072000.0,"ordinaryProfit":2666037000.0,"extraordinaryGain":null,"extraordinaryLoss":162182000.0,"incomeBeforeTax":2503854000.0,"incomeTaxes":785118000.0,"netIncome":1718735000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1718735000.0,"comprehensiveIncome":1701016000.0,"eps":113.24,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/5\/7","stockCode":9267,"accountingYear":null,"accountingYearStart":"2019\/6\/21","accountingYearEnd":"2020\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2020\/6\/20","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1143.0,"averageTemporaryStaff":1969.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9226229.0,"sharesOwendPercent":0.6079,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1823.51,"equityRatio":0.333,"cashAndCashEquivalents":6620920000.0,"assets":83145081000.0,"currentAssets":29283786000.0,"fixedAsset":53861294000.0,"tangibleFixedAssets":47839507000.0,"intangibleFixedAssets":303383000.0,"investmentAndOtherAssets":5718403000.0,"liabilities":55459525000.0,"currentLiabilities":28964723000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":5919154000.0,"fixedLiabilities":26494801000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":24113930000.0,"netAsset":27685556000.0,"capitalStock":27654128000.0,"capital":1000000000.0,"capitalSurplus":6795251000.0,"accumulatedEarnings":20647690000.0,"treasuryStock":-788813000.0,"valuationAndConversionAdjustments":21916000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":123603000000.0,"costOfSales":96891266000.0,"grossProfit":26712227000.0,"sgaExpenses":22370496000.0,"salaryAndBenefit":null,"depreciationAndSGA":3443032000.0,"RDExpenses":null,"operatingIncome":4341730000.0,"nonOperatingIncome":622082000.0,"nonOperatingExpenses":397623000.0,"interestExpense":61725000.0,"ordinaryProfit":4566190000.0,"extraordinaryGain":null,"extraordinaryLoss":534058000.0,"incomeBeforeTax":4032132000.0,"incomeTaxes":1277108000.0,"netIncome":2755024000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2755024000.0,"comprehensiveIncome":2745791000.0,"eps":181.52,"dilutedEps":null,"dividendPerShare":null,"per":18.5,"roe":0.104,"cashFlowFromOperatingActivities":7411057000.0,"depreciationAndCashflowFromOperatingActivities":3761478000.0,"cashFlowFromInvestingActivities":-11222720000.0,"cashFlowFromFinancialActivities":7989055000.0,"changesInCashAndCashEquivalents":4177245000.0,"列1":"asr","submitDate":"2020\/9\/7","stockCode":9267,"accountingYear":"第３期(自　2019年６月21日　至　2020年６月20日)","accountingYearStart":"2019\/6\/21","accountingYearEnd":"2020\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2020\/9\/20","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.336,"cashAndCashEquivalents":null,"assets":85794923000.0,"currentAssets":31527146000.0,"fixedAsset":54267777000.0,"tangibleFixedAssets":48178503000.0,"intangibleFixedAssets":300508000.0,"investmentAndOtherAssets":5788764000.0,"liabilities":57001140000.0,"currentLiabilities":32547240000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":6547766000.0,"fixedLiabilities":24453899000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":22077315000.0,"netAsset":28793783000.0,"capitalStock":28752315000.0,"capital":1000000000.0,"capitalSurplus":6605534000.0,"accumulatedEarnings":21935757000.0,"treasuryStock":-788976000.0,"valuationAndConversionAdjustments":28499000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":35075349000.0,"costOfSales":27495065000.0,"grossProfit":7580283000.0,"sgaExpenses":5859028000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1721255000.0,"nonOperatingIncome":149669000.0,"nonOperatingExpenses":69093000.0,"interestExpense":11031000.0,"ordinaryProfit":1801830000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":1801830000.0,"incomeTaxes":513763000.0,"netIncome":1288067000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1288067000.0,"comprehensiveIncome":1294650000.0,"eps":84.87,"dilutedEps":84.78,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/11\/2","stockCode":9267,"accountingYear":null,"accountingYearStart":"2020\/6\/21","accountingYearEnd":"2021\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2020\/12\/20","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9533497.0,"sharesOwendPercent":0.6281,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.364,"cashAndCashEquivalents":4057076000.0,"assets":82290663000.0,"currentAssets":27751468000.0,"fixedAsset":54539195000.0,"tangibleFixedAssets":48763730000.0,"intangibleFixedAssets":312592000.0,"investmentAndOtherAssets":5462872000.0,"liabilities":52343177000.0,"currentLiabilities":29778165000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":6752459000.0,"fixedLiabilities":22565011000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":20414619000.0,"netAsset":29947486000.0,"capitalStock":29900329000.0,"capital":1000000000.0,"capitalSurplus":6605534000.0,"accumulatedEarnings":23084153000.0,"treasuryStock":-789358000.0,"valuationAndConversionAdjustments":31036000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":69117142000.0,"costOfSales":54230495000.0,"grossProfit":14886646000.0,"sgaExpenses":11655686000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3230959000.0,"nonOperatingIncome":347670000.0,"nonOperatingExpenses":155989000.0,"interestExpense":25545000.0,"ordinaryProfit":3422640000.0,"extraordinaryGain":111949000.0,"extraordinaryLoss":56192000.0,"incomeBeforeTax":3478396000.0,"incomeTaxes":1041933000.0,"netIncome":2436463000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2436463000.0,"comprehensiveIncome":2445582000.0,"eps":160.53,"dilutedEps":160.39,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":3900044000.0,"depreciationAndCashflowFromOperatingActivities":1947169000.0,"cashFlowFromInvestingActivities":-3368540000.0,"cashFlowFromFinancialActivities":-3095351000.0,"changesInCashAndCashEquivalents":-2563843000.0,"列1":"q2r","submitDate":"2021\/1\/29","stockCode":9267,"accountingYear":null,"accountingYearStart":"2020\/6\/21","accountingYearEnd":"2021\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2021\/3\/20","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.372,"cashAndCashEquivalents":null,"assets":82521588000.0,"currentAssets":26378089000.0,"fixedAsset":56143498000.0,"tangibleFixedAssets":50275981000.0,"intangibleFixedAssets":345812000.0,"investmentAndOtherAssets":5521705000.0,"liabilities":51778728000.0,"currentLiabilities":29175589000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":6692209000.0,"fixedLiabilities":22603139000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":20433294000.0,"netAsset":30742859000.0,"capitalStock":30686709000.0,"capital":1000000000.0,"capitalSurplus":6415819000.0,"accumulatedEarnings":24060374000.0,"treasuryStock":-789484000.0,"valuationAndConversionAdjustments":37379000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":103451000000.0,"costOfSales":81404146000.0,"grossProfit":22046690000.0,"sgaExpenses":17399998000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":4646692000.0,"nonOperatingIncome":468492000.0,"nonOperatingExpenses":254711000.0,"interestExpense":36635000.0,"ordinaryProfit":4860473000.0,"extraordinaryGain":111949000.0,"extraordinaryLoss":56192000.0,"incomeBeforeTax":4916229000.0,"incomeTaxes":1503544000.0,"netIncome":3412684000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3412684000.0,"comprehensiveIncome":3428147000.0,"eps":224.86,"dilutedEps":224.63,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/4\/30","stockCode":9267,"accountingYear":null,"accountingYearStart":"2020\/6\/21","accountingYearEnd":"2021\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2021\/6\/20","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1501.0,"averageTemporaryStaff":2301.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9703674.0,"sharesOwendPercent":0.6394,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2117.96,"equityRatio":0.354,"cashAndCashEquivalents":7913261000.0,"assets":90795455000.0,"currentAssets":32140487000.0,"fixedAsset":58654968000.0,"tangibleFixedAssets":52527616000.0,"intangibleFixedAssets":394116000.0,"investmentAndOtherAssets":5733235000.0,"liabilities":58628956000.0,"currentLiabilities":34641768000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":6816659000.0,"fixedLiabilities":23987187000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":21684175000.0,"netAsset":32166499000.0,"capitalStock":32105680000.0,"capital":1000000000.0,"capitalSurplus":6415819000.0,"accumulatedEarnings":25479345000.0,"treasuryStock":-789484000.0,"valuationAndConversionAdjustments":38885000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":142376000000.0,"costOfSales":112087000000.0,"grossProfit":30289461000.0,"sgaExpenses":23994505000.0,"salaryAndBenefit":null,"depreciationAndSGA":3742418000.0,"RDExpenses":null,"operatingIncome":6294955000.0,"nonOperatingIncome":645885000.0,"nonOperatingExpenses":339163000.0,"interestExpense":55517000.0,"ordinaryProfit":6601677000.0,"extraordinaryGain":117488000.0,"extraordinaryLoss":56192000.0,"incomeBeforeTax":6662972000.0,"incomeTaxes":1831316000.0,"netIncome":4831655000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4831655000.0,"comprehensiveIncome":4848624000.0,"eps":318.35,"dilutedEps":318.03,"dividendPerShare":null,"per":11.7,"roe":0.162,"cashFlowFromOperatingActivities":12075282000.0,"depreciationAndCashflowFromOperatingActivities":4058681000.0,"cashFlowFromInvestingActivities":-8829485000.0,"cashFlowFromFinancialActivities":-1953473000.0,"changesInCashAndCashEquivalents":1292341000.0,"列1":"asr","submitDate":"2021\/9\/6","stockCode":9267,"accountingYear":"第４期(自　2020年６月21日　至　2021年６月20日)","accountingYearStart":"2020\/6\/21","accountingYearEnd":"2021\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2021\/9\/20","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.369,"cashAndCashEquivalents":null,"assets":89993763000.0,"currentAssets":30687807000.0,"fixedAsset":59305955000.0,"tangibleFixedAssets":53136684000.0,"intangibleFixedAssets":392879000.0,"investmentAndOtherAssets":5776391000.0,"liabilities":56788880000.0,"currentLiabilities":32874979000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":6770882000.0,"fixedLiabilities":23913900000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":21598994000.0,"netAsset":33204882000.0,"capitalStock":33159385000.0,"capital":1000000000.0,"capitalSurplus":6415819000.0,"accumulatedEarnings":26533280000.0,"treasuryStock":-789714000.0,"valuationAndConversionAdjustments":20961000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":39118424000.0,"costOfSales":31172789000.0,"grossProfit":7945635000.0,"sgaExpenses":6207472000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1738162000.0,"nonOperatingIncome":219398000.0,"nonOperatingExpenses":106921000.0,"interestExpense":8091000.0,"ordinaryProfit":1850639000.0,"extraordinaryGain":null,"extraordinaryLoss":2959000.0,"incomeBeforeTax":1847680000.0,"incomeTaxes":615472000.0,"netIncome":1232207000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1232207000.0,"comprehensiveIncome":1214283000.0,"eps":81.19,"dilutedEps":81.09,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/11\/2","stockCode":9267,"accountingYear":null,"accountingYearStart":"2021\/6\/21","accountingYearEnd":"2022\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0},{"edinetCode":"E33416","endDate":"2021\/12\/20","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":10311609.0,"sharesOwendPercent":0.6794,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.37,"cashAndCashEquivalents":4346749000.0,"assets":92022198000.0,"currentAssets":30184716000.0,"fixedAsset":61837481000.0,"tangibleFixedAssets":55685024000.0,"intangibleFixedAssets":393884000.0,"investmentAndOtherAssets":5758572000.0,"liabilities":57901187000.0,"currentLiabilities":34833295000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":7526111000.0,"fixedLiabilities":23067891000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":20762104000.0,"netAsset":34121011000.0,"capitalStock":34069212000.0,"capital":1004848000.0,"capitalSurplus":6420667000.0,"accumulatedEarnings":27433411000.0,"treasuryStock":-789714000.0,"valuationAndConversionAdjustments":18307000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":76241162000.0,"costOfSales":61057615000.0,"grossProfit":15183546000.0,"sgaExpenses":12261947000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2921599000.0,"nonOperatingIncome":413670000.0,"nonOperatingExpenses":208787000.0,"interestExpense":26695000.0,"ordinaryProfit":3126482000.0,"extraordinaryGain":null,"extraordinaryLoss":2959000.0,"incomeBeforeTax":3123523000.0,"incomeTaxes":991184000.0,"netIncome":2132338000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2132338000.0,"comprehensiveIncome":2111760000.0,"eps":140.5,"dilutedEps":140.3,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":634186000.0,"depreciationAndCashflowFromOperatingActivities":2190935000.0,"cashFlowFromInvestingActivities":-3789514000.0,"cashFlowFromFinancialActivities":-411176000.0,"changesInCashAndCashEquivalents":-3566511000.0,"列1":"q2r","submitDate":"2022\/2\/2","stockCode":9267,"accountingYear":null,"accountingYearStart":"2021\/6\/21","accountingYearEnd":"2022\/6\/20","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E33416","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":1000,"settlementDate":"2022\/6\/20","submitterName":"Ｇｅｎｋｙ　ＤｒｕｇＳｔｏｒｅｓ株式会社","submitterNameEnglish":"Genky DrugStores Co., Ltd.","submitterNameKana":"ゲンキードラッグストアーズカブシキガイシャ","location":"坂井市丸岡町下久米田３８字３３番","industory":"小売業","corporateNumber":5210000000000.0}]